Cargando…

Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis

We retrospectively analyzed the safety and efficacy of cyclophosphamide (cyclo) for salvage treatment of chronic graft-versus-host disease (cGvHD) and cGvHD-associated (glomerulo-)nephritis at our center between 01/2010 and 11/2019. We identified 13 patients (pts) receiving cyclo for treatment of mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fante, Matthias A., Holler, Barbara, Weber, Daniela, Angstwurm, Klemens, Bergler, Tobias, Holler, Ernst, Edinger, Matthias, Herr, Wolfgang, Wertheimer, Tobias, Wolff, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419371/ https://www.ncbi.nlm.nih.gov/pubmed/32715339 http://dx.doi.org/10.1007/s00277-020-04193-1

Ejemplares similares

Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis
por: Wertheimer, Tobias, et al.
Publicado: (2021)

Parametric Imaging of Contrast-Enhanced Ultrasound (CEUS) for the Evaluation of Acute Gastrointestinal Graft-Versus-Host Disease
por: Pausch, Antonia-Maria, et al.
Publicado: (2021)

IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
por: Kattner, Anna-Sophia, et al.
Publicado: (2020)

Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation
por: Gruber, Isabella, et al.
Publicado: (2022)

Microbiota and Graft-versus Host disease: a double-edged sword
por: Holler, Ernst, et al.
Publicado: (2019)

Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Kraus, Peter D., et al.
Publicado: (2012)

“This Graft-vs.-Host Disease Determines My Life. That's It.”—A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany
por: Parisek, Mira, et al.
Publicado: (2021)

Intestinal IgA-positive plasma cells are highly sensitive indicators of alloreaction early after allogeneic transplantation and associate with both graft-versus-host disease and relapse-related mortality
por: Scheidler, Lucia, et al.
Publicado: (2023)

The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation
por: Weber, Daniela, et al.
Publicado: (2017)

Analysis of long-term mortality after total body irradiation-based and melphalan-based chemotherapy conditioning for acute myeloid leukemia
por: Gruber, Isabella, et al.
Publicado: (2023)

Downregulation of the vitamin D receptor expression during acute gastrointestinal graft versus host disease is associated with poor outcome after allogeneic stem cell transplantation
por: Matos, Carina, et al.
Publicado: (2022)

A qualitative study on patients’ and their support persons’ preferences for receiving one longer consultation or two shorter consultations when being informed about allogeneic hematopoietic stem cell transplantation
por: Herrmann, Anne, et al.
Publicado: (2021)

Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2020)

Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation–An Analysis of 2 German Transplantation Centers
por: Wolff, Daniel, et al.
Publicado: (2020)

The lung function score and its components as predictors of overall survival and chronic graft-vs-host disease after allogeneic stem cell transplantation
por: Ditz, Diana, et al.
Publicado: (2016)

Low Intestinal IL22 Associates With Increased Transplant-Related Mortality After Allogeneic Stem Cell Transplantation
por: Ghimire, Sakhila, et al.
Publicado: (2022)

Human bocavirus 1 respiratory tract reactivations or reinfections in two adults, contributing to neurological deficits and death
por: Rayamajhi Thapa, Rajita, et al.
Publicado: (2021)

GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics
por: Ghimire, Sakhila, et al.
Publicado: (2021)

An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host disease
por: Kreft, Andreas, et al.
Publicado: (2021)

THE INDUCTION OF GRAFT VERSUS HOST DISEASE IN MICE TREATED WITH CYCLOPHOSPHAMIDE
por: Owens, Albert H., et al.
Publicado: (1968)

Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow Transplantation
por: Schmid, Peter M., et al.
Publicado: (2017)

Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy
por: Kattner, Anna-Sophia, et al.
Publicado: (2020)

The Nlrp3 inflammasome regulates acute graft-versus-host disease
por: Jankovic, Dragana, et al.
Publicado: (2013)

Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation
por: Ullrich, Evelyn, et al.
Publicado: (2016)

Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
por: Ardizzoia, Federica, et al.
Publicado: (2022)

Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use
por: Weber, Daniela, et al.
Publicado: (2022)

Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
por: Roll, D., et al.
Publicado: (2011)

EBMT—NIH—CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
por: Schoemans, Helene M., et al.
Publicado: (2018)

Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding
por: Nunes, Natalia S., et al.
Publicado: (2019)

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease
por: Lüke, Florian, et al.
Publicado: (2021)

Donor-type CD4(+)CD25(+) Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation
por: Hoffmann, Petra, et al.
Publicado: (2002)

Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models
por: Mashima, Kiyomi, et al.
Publicado: (2021)

Murine cytomegalovirus reactivation concomitant with acute graft-versus-host disease is controlled by antibodies
por: Seefried, Martina, et al.
Publicado: (2023)

Round-Robin test for the histological diagnosis of acute colonic Graft-versus-Host disease validating established histological criteria and grading systems
por: Hippe, Katrin, et al.
Publicado: (2023)

Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects
por: Meinhardt, Kathrin, et al.
Publicado: (2015)

B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Juric, Mateja Kralj, et al.
Publicado: (2017)

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial
por: Broers, Annoek E. C., et al.
Publicado: (2022)

Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health
por: Wolff, Daniel, et al.
Publicado: (2020)

Correction: Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health
por: Wolff, Daniel, et al.
Publicado: (2021)

1,25-dihydroxyvitamin-D3 but not the clinically applied marker 25-hydroxyvitamin-D3 predicts survival after stem cell transplantation
por: Peter, Katrin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lgmj4d1765e8m2oq08pp36pj2a